GSK Executives Facing Graft Charges in China

, The American Lawyer

   | 0 Comments

China has accused the former head of GlaxoSmithKline’s operations in that country and two other employees of ordering subordinates to bribe doctors and health care officials in an effort boost the company's revenue

What's being said

Comments are not moderated. To report offensive comments, click here.

Preparing comment abuse report for Article# 1202655377198

Thank you!

This article's comments will be reviewed.